Table 1.
Differential analysis of lung function and chest HRCT in patients with CPFE 12 months after treated with ICS/LABA
| Group | FEV1% | FVC% | DLCO% | HRCT score | ||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Treatment group (n=45) | Control group (n=24) | Treatment group (n=45) | Control group (n=24) | Treatment group (n=45) | Control group (n=24) | Treatment group (n=45) | Control group (n=24) | |
| 0 month | 54.07±8.69 | 57.13±10.04* | 52.36±8.83 | 57.63±10.75* | 46.49±7.91 | 55.5±6.66# | 36.6±5.47 | 31.21±6.73 |
| 3 months | 55.57±8.69 | 53.04±10.03* | 56.27±8.21 | 54.67±8.24* | 50.47±7.36 | 50.5±6.87* | 31.16±5.23 | 33.54±5.88 |
| 6 months | 60.32±5.84 | 49.29±9.45# | 60.31±7.63 | 49.83±8.83# | 53.29±7.68 | 45.96±6.78# | 28.51±4.94 | 36.75±5.08 |
| 9 months | 62.77±4.54 | 44.96±8.64# | 63.11±7.53 | 45.42±7.51# | 55.16±7.47 | 40.13±7.24# | 27.53±5.05 | 40.63±3.81 |
| 12 months | 65.27±4.86 | 42.92±7.86# | 65.89±8.05 | 40.83±7.81# | 57.29±7.17 | 34.25±7.01# | 27.29±5.13 | 46.08±2.17 |
| F value | 35.63618 | 26.02683 | 17.83554 | 40.70971 | ||||
| P value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | ||||
*
There was no significant difference between two groups (P>0.05);
#
There was significant difference between two groups (P<0.05).